Immune therapy is a new class of cancer treatment designed to boost or enhance the body?s immune system to more efficiently target and destroy cancerous cells. Many experts believe that immunotherapy represents the most promising new cancer treatment since the development of chemotherapy.
This report aims to provide a comprehensive presentation of the global market for Immunocell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunocell Therapy. This report contains market size and forecasts of Immunocell Therapy in global, including the following market information:
Global Immunocell Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Immunocell Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Chimeric Antigen Receptor (CAR) T Cell Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Immunocell Therapy include Gilead Sciences and Novartis etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Immunocell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immunocell Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Immunocell Therapy Market Segment Percentages, by Type, 2022 (%)
Chimeric Antigen Receptor (CAR) T Cell Therapy
Natural Killer (NK) Cell Therapy
Others
Global Immunocell Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Immunocell Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Immunocell Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Immunocell Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immunocell Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Immunocell Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead Sciences
Novartis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Immunocell Therapy, market overview.
Chapter 2: Global Immunocell Therapy market size in revenue.
Chapter 3: Detailed analysis of Immunocell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immunocell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Immunocell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immunocell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immunocell Therapy Overall Market Size
2.1 Global Immunocell Therapy Market Size: 2022 VS 2029
2.2 Global Immunocell Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immunocell Therapy Players in Global Market
3.2 Top Global Immunocell Therapy Companies Ranked by Revenue
3.3 Global Immunocell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Immunocell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Immunocell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immunocell Therapy Players in Global Market
3.6.1 List of Global Tier 1 Immunocell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Immunocell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Immunocell Therapy Market Size Markets, 2022 & 2029
4.1.2 Chimeric Antigen Receptor (CAR) T Cell Therapy
4.1.3 Natural Killer (NK) Cell Therapy
4.1.4 Others
4.2 By Type - Global Immunocell Therapy Revenue & Forecasts
4.2.1 By Type - Global Immunocell Therapy Revenue, 2018-2023
4.2.2 By Type - Global Immunocell Therapy Revenue, 2024-2029
4.2.3 By Type - Global Immunocell Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immunocell Therapy Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Immunocell Therapy Revenue & Forecasts
5.2.1 By Application - Global Immunocell Therapy Revenue, 2018-2023
5.2.2 By Application - Global Immunocell Therapy Revenue, 2024-2029
5.2.3 By Application - Global Immunocell Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Immunocell Therapy Market Size, 2022 & 2029
6.2 By Region - Global Immunocell Therapy Revenue & Forecasts
6.2.1 By Region - Global Immunocell Therapy Revenue, 2018-2023
6.2.2 By Region - Global Immunocell Therapy Revenue, 2024-2029
6.2.3 By Region - Global Immunocell Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Immunocell Therapy Revenue, 2018-2029
6.3.2 US Immunocell Therapy Market Size, 2018-2029
6.3.3 Canada Immunocell Therapy Market Size, 2018-2029
6.3.4 Mexico Immunocell Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Immunocell Therapy Revenue, 2018-2029
6.4.2 Germany Immunocell Therapy Market Size, 2018-2029
6.4.3 France Immunocell Therapy Market Size, 2018-2029
6.4.4 U.K. Immunocell Therapy Market Size, 2018-2029
6.4.5 Italy Immunocell Therapy Market Size, 2018-2029
6.4.6 Russia Immunocell Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Immunocell Therapy Market Size, 2018-2029
6.4.8 Benelux Immunocell Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Immunocell Therapy Revenue, 2018-2029
6.5.2 China Immunocell Therapy Market Size, 2018-2029
6.5.3 Japan Immunocell Therapy Market Size, 2018-2029
6.5.4 South Korea Immunocell Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Immunocell Therapy Market Size, 2018-2029
6.5.6 India Immunocell Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Immunocell Therapy Revenue, 2018-2029
6.6.2 Brazil Immunocell Therapy Market Size, 2018-2029
6.6.3 Argentina Immunocell Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Immunocell Therapy Revenue, 2018-2029
6.7.2 Turkey Immunocell Therapy Market Size, 2018-2029
6.7.3 Israel Immunocell Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Immunocell Therapy Market Size, 2018-2029
6.7.5 UAE Immunocell Therapy Market Size, 2018-2029
7 Immunocell Therapy Companies Profiles
7.1 Gilead Sciences
7.1.1 Gilead Sciences Company Summary
7.1.2 Gilead Sciences Business Overview
7.1.3 Gilead Sciences Immunocell Therapy Major Product Offerings
7.1.4 Gilead Sciences Immunocell Therapy Revenue in Global Market (2018-2023)
7.1.5 Gilead Sciences Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Immunocell Therapy Major Product Offerings
7.2.4 Novartis Immunocell Therapy Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Immunocell Therapy Market Opportunities & Trends in Global Market
Table 2. Immunocell Therapy Market Drivers in Global Market
Table 3. Immunocell Therapy Market Restraints in Global Market
Table 4. Key Players of Immunocell Therapy in Global Market
Table 5. Top Immunocell Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Immunocell Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Immunocell Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Immunocell Therapy Product Type
Table 9. List of Global Tier 1 Immunocell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immunocell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Immunocell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Immunocell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Immunocell Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Immunocell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Immunocell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Immunocell Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Immunocell Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Immunocell Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Immunocell Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Immunocell Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Immunocell Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Immunocell Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Immunocell Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Immunocell Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Immunocell Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Immunocell Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Immunocell Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Immunocell Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Immunocell Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Gilead Sciences Company Summary
Table 31. Gilead Sciences Immunocell Therapy Product Offerings
Table 32. Gilead Sciences Immunocell Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Gilead Sciences Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Immunocell Therapy Product Offerings
Table 36. Novartis Immunocell Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
List of Figures
Figure 1. Immunocell Therapy Segment by Type in 2022
Figure 2. Immunocell Therapy Segment by Application in 2022
Figure 3. Global Immunocell Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Immunocell Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Immunocell Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immunocell Therapy Revenue in 2022
Figure 8. By Type - Global Immunocell Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Immunocell Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Immunocell Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Immunocell Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Immunocell Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Immunocell Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Immunocell Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Immunocell Therapy Revenue Market Share, 2018-2029
Figure 16. US Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Immunocell Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Immunocell Therapy Revenue Market Share, 2018-2029
Figure 28. China Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Immunocell Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Immunocell Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Immunocell Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Gilead Sciences Immunocell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Immunocell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
